Literature DB >> 27284161

BSR and BHPR guideline for the treatment of systemic sclerosis.

Christopher P Denton1, Michael Hughes2, Nataliya Gak3, Josephine Vila4, Maya H Buch5, Kuntal Chakravarty3, Kim Fligelstone3, Luke L Gompels6, Bridget Griffiths4, Ariane L Herrick2, Jay Pang7, Louise Parker8, Anthony Redmond5, Jacob van Laar9, Louise Warburton10, Voon H Ong3.   

Abstract

Entities:  

Keywords:  Raynaud’s phenomenon; digital ulcers; lung fibrosis; management; pulmonary hypertension; scleroderma; systemic sclerosis

Mesh：

Year:  2016        PMID： 27284161     DOI： 10.1093/rheumatology/kew224

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  39 in total

1.  Connective tissue disease: Reflections on the EULAR recommendations for the treatment of systemic sclerosis.

Authors:  Janet E Pope
Journal:  Nat Rev Rheumatol       Date:  2017-01-05       Impact factor: 20.543

Review 2.  Evidence-based management of Raynaud's phenomenon.

Authors:  Ariane L Herrick
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-20       Impact factor: 5.346

3.  [Raynaud's phenomenon : Practical management].

Authors:  C Drerup; A Maier; J Ehrchen
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

4.  Drug initiation and escalation strategies of vasodilator therapies for Raynaud's phenomenon: can we treat to target?

Authors:  Michael Hughes; Dinesh Khanna; John D Pauling
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

Review 5.  Lung Manifestations in the Rheumatic Diseases.

Authors:  Tracy J Doyle; Paul F Dellaripa
Journal:  Chest       Date:  2017-05-25       Impact factor: 9.410

Review 6.  [Current treatment of systemic scleroderma].

Authors:  Nicolas Hunzelmann
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

Review 7.  Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review.

Authors:  Winifred Ekezie; Rachael L Murray; Sanjay Agrawal; Ilze Bogdanovica; John Britton; Jo Leonardi-Bee
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

8.  Raynaud's phenomenon.

Authors:  Ashraful Haque; Michael Hughes
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

9.  Differing commissioning arrangements may contribute to geographic variation in clinical management of digital ulcers in systemic sclerosis.

Authors:  Elizabeth Reilly; Randa Alshakh; Celia Beynon; Matthew Cates; Dhivya Das; Shuja Majeed; Ahsan Memon; Patrick O'Beirn; James Ritchie; John D Pauling
Journal:  Clin Med (Lond)       Date:  2020-05       Impact factor: 2.659

10.  Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial.

Authors:  Nupoor Acharya; Shefali Khanna Sharma; Debashish Mishra; Sahajal Dhooria; Varun Dhir; Sanjay Jain
Journal:  Rheumatol Int       Date:  2020-04-01       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.